On October 18, 2016, Getinge announced its intention to distribute the subsidiary Arjo to Getinge’s shareholders and to list Arjo on Nasdaq Stockholm.
The preparatory work has, as regularly communicated, proceeded according to plan. The Board of Directors of Getinge proposed on November 10, 2017 that, at an Extraordinary General Meeting to be held on December 4, 2017, the shareholders of Getinge resolve to distribute all of the shares in Arjo to the shareholders of Getinge. The first day of trading in Arjo shares is expected to be December 12, 2017.
At Arjo, we are committed to improving the everyday lives of people affected by reduced mobility and age-related health challenges. With products and solutions that ensure ergonomic patient handling, personal hygiene, disinfection, diagnostics, and the effective prevention of pressure ulcers and venous thromboembolism, we help professionals across care environments to continually raise the standard of safe and dignified care. Arjo has over 5,900 employees worldwide and customers in over 60 countries. In 2016 the Arjo sales amounted to about SEK 8 billion.
Information about the Extraordinary General Meeting, 4 December 2017.
Below you find documents related to the distribution and listing of Arjo.
Вы покидаете сайт Getinge.com. Вы можете получить доступ к контенту, не управляемому командой Getinge, и в этом случае Getinge не несет ответственности за этот контент.